Intravitreal triamcinolone acetonide, retinal microglia and retinal ganglion cell apoptosis in the optic nerve crush model

Acta Ophthalmologica

Volumn 94, Issue 5, 2016, Pages e305-e311

  Wang, Jiawei ^a   Chen, Shida ^a   Zhang, Xiulan ^a   Huang, Wenbin ^a   Jonas, Jost B ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

intravitreal triamcinolone; optic nerve; optic nerve crush; retinal ganglion cells; retinal microglial cells

Indexed keywords

EOSIN; HEMATOXYLIN; PHOSPHATE BUFFERED SALINE; TRIAMCINOLONE ACETONIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL DENSITY; CELL LABELING; CELL LOSS; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; IMMUNOHISTOCHEMISTRY; MICROGLIA; MICROSCOPY; NONHUMAN; OPTIC NERVE CRUSH; OPTIC NERVE DISEASE; PRIORITY JOURNAL; RAT; RETINA EXAMINATION; RETINA GANGLION CELL; RETINAL MICROGLIA; WESTERN BLOTTING;

EID: 84978933440     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/aos.12698     Document Type: Article

References (40)

1. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG & Gardner TW (1998): Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 102: 783–791.
2. Beer PM, Bakri SJ, Singh RJ, Liu W, Peters GB III & Miller M (2003): Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 110: 681–686.
3. Bodeutsch N, Siebert H, Dermon C & Thanos S (1999): Unilateral injury to the adult rat optic nerve causes multiple cellular responses in the contralateral site. J Neurobiol 38: 116–128.
4. Bui BV, Loeliger M, Thomas M, Vingrys AJ, Rees SM, Nguyen CT, He Z & Tolcos M (2009): Investigating structural and biochemical correlates of ganglion cell dysfunction in streptozotocin-induced diabetic rats. Exp Eye Res 88: 1076–1083.
5. Cho KJ, Kim JH, Park HY & Park CK (2011): Glial cell response and iNOS expression in the optic nerve head and retina of the rat following acute high IOP ischemia-reperfusion. Brain Res 1403: 67–77.
6. Ertel W, Keel M, Bonaccio M, Steckholzer U, Gallati H, Kenney JS & Trentz O (1995): Release of anti-inflammatory mediators after mechanical trauma correlates with severity of injury and clinical outcome. J Trauma 39: 879–885.
7. Frade JM & Barde YA (1998): Microglia-derived nerve growth factor causes cell death in the developing retina. Neuron 20: 35–41.
8. Fraunfelder FW (2007): Drug-induced ocular inflammatory diseases. Drugs Today (Barc) 43: 117–123.
9. Galindo-Romero C, Valiente-Soriano FJ, Jimenez-Lopez M, García-Ayuso D, Villegas-Pérez MP, Vidal-Sanz M & Agudo-Barriuso M (2013): Effect of brain-derived neurotrophic factor on mouse axotomized retinal ganglion cells and phagocytic microglia. Invest Ophthalmol Vis Sci 54: 974–985.
10. Gehrmann J, Matsumoto Y & Kreutzberg GW (1995): Microglia: intrinsic immuneffector cell of the brain. Brain Res Brain Res Rev 20: 269–287.
11. Hanisch UK & Kettenmann H (2007): Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10: 1387–1394.
12. Harada T, Harada C, Kohsaka S et al. (2002): Microglia-Muller glia cell interactions control neurotrophic factor production during light-induced retinal degeneration. J Neurosci 22: 9228–9236.
13. Hong J, Kim BK, Lim H, Lee S & Lee SJ (2012): Identification and characterization of triamcinolone acetonide, a microglial-activation inhibitor. Immunopharmacol Immunotoxicol 34: 912–918.
14. Huang TL, Chang CH, Lin KH, Sheu MM & Tsai RK (2011): Lack of protective effect of local administration of triamcinolone or systemic treatment with methylprednisolone against damages caused by optic nerve crush in rats. Exp Eye Res 92: 112–119.
15. Jonas JB (2005): Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases. Acta Ophthalmol Scand 83: 645–663.
16. Jonas RA, Yuan TF, Liang YX, Jonas JB, Tay DK & Ellis-Behnke RG (2012): The spider effect: morphological and orienting classification of microglia in response to stimuli in vivo. PLoS ONE 7: e30763.
17. Kim YH, Choi MY, Kim YS et al. (2007): Triamcinolone acetonide protects the rat retina from STZ-induced acute inflammation and early vascular leakage. Life Sci 81: 1167–1173.
18. Knoblach SM, Fan L & Faden AI (1999): Early neuronal expression of tumor necrosis factor-alpha after experimental brain injury contributes to neurological impairment. J Neuroimmunol 95: 115–125.
19. Krady JK, Basu A, Allen CM, Xu Y, LaNoue KF, Gardner TW & Levison SW (2005): Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes 54: 1559–1565.
20. Lehmann U, Heuss ND, McPherson SW, Roehrich H & Gregerson DS (2010): Dendritic cells are early responders to retinal injury. Neurobiol Dis 40: 177–184.
21. Liu S, Li ZW, Weinreb RN et al. (2012): Tracking retinal microgliosis in models of retinal ganglion cell damage. Invest Ophthalmol Vis Sci 53: 6254–6262.
22. Lucas SM, Rothwell NJ & Gibson RM (2006): The role of inflammation in CNS injury and disease. Br J Pharmacol 147(Suppl. 1): S232–S240.
23. Ma K, Xu L, Zhang H, Zhang S, Pu M & Jonas JB (2009): Effect of brimonidine on retinal ganglion cell survival in an optic nerve crush model. Am J Ophthalmol 147: 326–331.
24. Moore S & Thanos S (1996): The concept of microglia in relation to central nervous system disease and regeneration. Prog Neurobiol 48: 441–460.
25. Nadal-Nicolas FM, Jimenez-Lopez M, Sobrado-Calvo P, Nieto-López L, Cánovas-Martínez I, Salinas-Navarro M, Vidal-Sanz M & Agudo M (2009): Brn3a as a marker of retinal ganglion cells: qualitative and quantitative time course studies in naive and optic nerve-injured retinas. Invest Ophthalmol Vis Sci 50: 3860–3868.
26. Nan K, Sun S, Li Y, Qu J, Li G, Luo L, Chen H & Cheng L (2010): Characterisation of systemic and ocular drug level of triamcinolone acetonide following a single sub-Tenon injection. Br J Ophthalmol 94: 654–658.
27. Ohlsson M, Bellander BM, Langmoen IA & Svensson M (2003): Complement activation following optic nerve crush in the adult rat. J Neurotrauma 20: 895–904.
28. Penfold PL, Wong JG, Gyory J & Billson FA (2001): Effects of triamcinolone acetonide on microglial morphology and quantitative expression of MHC-II in exudative age-related macular degeneration. Clin Experiment Ophthalmol 29: 188–192.
29. Rungger-Brandle E, Dosso AA & Leuenberger PM (2000): Glial reactivity, an early feature of diabetic retinopathy. Invest Ophthalmol Vis Sci 41: 1971–1980.
30. Singhal S, Lawrence JM, Salt TE, Khaw PT & Limb GA (2010): Triamcinolone attenuates macrophage/microglia accumulation associated with NMDA-induced RGC death and facilitates survival of Muller stem cell grafts. Exp Eye Res 90: 308–315.
31. Srinivasan B, Roque CH, Hempstead BL, Al-Ubaidi MR & Roque RS (2004): Microglia-derived pronerve growth factor promotes photoreceptor cell death via p75 neurotrophin receptor. J Biol Chem 279: 41839–41845.
32. Sun F, Park KK, Belin S et al. (2011): Sustained axon regeneration induced by co-deletion of PTEN and SOCS3. Nature 480: 372–375.
33. Tezel G, Yang X, Yang J & Wax MB (2004): Role of tumor necrosis factor receptor-1 in the death of retinal ganglion cells following optic nerve crush injury in mice. Brain Res 996: 202–212.
34. Thanos S, Mey J & Wild M (1993): Treatment of the adult retina with microglia-suppressing factors retards axotomy-induced neuronal degradation and enhances axonal regeneration in vivo and in vitro. J Neurosci 13: 455–466.
35. Tonari M, Kurimoto T, Horie T, Sugiyama T, Ikeda T & Oku H (2012): Blocking endothelin-B receptors rescues retinal ganglion cells from optic nerve injury through suppression of neuroinflammation. Invest Ophthalmol Vis Sci 53: 3490–3500.
36. Tsai RK, Chang CH & Wang HZ (2008): Neuroprotective effects of recombinant human granulocyte colony-stimulating factor (G-CSF) in neurodegeneration after optic nerve crush in rats. Exp Eye Res 87: 242–250.
37. Vigneswara V, Berry M, Logan A & Ahmed Z (2013): Pigment epithelium-derived factor is retinal ganglion cell neuroprotective and axogenic after optic nerve crush injury. Invest Ophthalmol Vis Sci 54: 2624–2633.
38. Yuan L & Neufeld AH (2000): Tumor necrosis factor-alpha: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head. Glia 2: 42–50.
39. Zhang R, Zhang H, Xu L, Ma K, Wallrapp C & Jonas JB (2011): Neuroprotective effect of intravitreal cell-based glucagon-like peptide-1 production in the optic nerve crush model. Acta Ophthalmol 89: e320–e326.
40. Zheng Z, Yuan R, Song M et al. (2012): The toll-like receptor 4-mediated signaling pathway is activated following optic nerve injury in mice. Brain Res 1489: 90–97.